Followers | 2 |
Posts | 1540 |
Boards Moderated | 0 |
Alias Born | 05/06/2017 |
Wednesday, May 19, 2021 2:48:04 AM
source
https://finance.sina.com.cn/stock/relnews/hk/2021-05-18/doc-ikmyaawc6107824.shtml
May 18, 2021 22:45 Straight Flush
CHINASOFTINTERNATIONALLIMITED Chinasoft International Co., Ltd. *
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 354)
Appointment of executive director and deputy chairman
The board of directors (the “Board”) of Chinasoft International Limited (the “Company”, together with its subsidiaries, collectively referred to as the “Group”) is pleased to announce that Dr. He Ning (“Dr. He”) has been appointed as the company’s executive director and Vice Chairman, effective from May 18, 2021.
Dr. He Ning, 59 years old, has more than 38 years of management experience in technology, operation, investment and other fields. His work experience is accompanied by the development of China's telecommunications and IT industry. He is familiar with the development rules of the TMT industry and has rich management and operation experience.
Dr. He graduated from Nanjing University of Posts and Telecommunications in 1983 with a bachelor's degree in automatic telephone switching. He later obtained a master's degree in business management from the Maastricht School of Management in the Netherlands in 2002; and in 2020 In 2005, he received a doctorate in business administration from the Hong Kong Polytechnic University.
Dr. He was appointed as an executive director and vice chairman of the board of directors of the company on May 18, 2021. Prior to this, Dr. Ho served as a director of the board of directors of China Telecom (Hong Kong) Co., Ltd. from August 1998 to June 2000 and China Mobile from June 2000 to January 2003 Director of the Board of Directors of (Hong Kong) Co., Ltd., Chairman and General Manager of Jiangsu Mobile Communications Co., Ltd., served as Director and Deputy General Manager of China Mobile (Hong Kong) Co., Ltd. from January 2003 to December 2005 , Served as the chairman and general manager of China Mobile Communications Group Beijing Co., Ltd. from December 2005 to February 2012, and served as China Mobile Communications Group Beijing Co., Ltd. from February 2012 to October 2015 Chairman and General Manager of Mobile Communication Group Terminal Co., Ltd., and
From October 2016 to September 2020, he served as the chairman of China Mobile Capital Holdings Co., Ltd. and the chairman of China Mobile Investment Holdings Co., Ltd. In addition, from September 2019 to November 2020, Dr. He also served as the chairman of 5G fund management company, executive director of China Mobile Venture Capital Co., Ltd., and China Mobile International Investment Innovation Investment Management Co., Ltd. Company director, director and supervisor of the National 100 Billion Industrial Investment Fund Co., Ltd.
Dr. Ho has entered into a service contract with the company for a term of three (3) years. Dr. He may receive a salary of RMB 2,400,000 per year plus an annual management bonus that does not exceed his annual salary. The company may award up to 5,000,000 ordinary shares of the company (the "rewarded shares") to Dr. Ho in accordance with the company's share award plan. The amount of management bonus and the number of such award shares will be determined by the board of directors at its sole discretion after taking into account the operating results of the Group and the performance of Dr. He. The salary, bonuses, and these award shares are determined by the board of directors after considering the recommendations of the remuneration committee, which has referenced current market benchmarks and his role and duties in the company. Dr. Ho shall retire by rotation and be re-elected in accordance with the company's articles of association.
Dr. Ho has not held any other positions in the Company or any of its subsidiaries, and has not held any other director positions in any public company listed on any securities market in Hong Kong or overseas in the past three years.
Dr. He has no relationship with any director, senior management, major shareholder or controlling shareholder of the company.
As of the date of this announcement, Dr. Ho does not have an interest as defined in Part XV of the Securities and Futures Ordinance, Chapter 571 of the Laws of Hong Kong and is deemed to have an interest in the shares or related shares of the Company.
There is no need to disclose any information about Dr. Ho in accordance with Rules 13.51(2)(h) to 13.51(2)(v) of the Securities Listing Rules of The Stock Exchange of Hong Kong Limited, nor any other matters related to the appointment of any doctor. Holders of the company’s securities.
The board of directors would like to warmly welcome Dr. He to join the board of directors.
By order of the board of directors
Chinasoft International Co., Ltd.
Chairman and Chief Executive Officer
Dr. Chen Yuhong
Hong Kong, May 18, 2021
As of the date of this announcement, the board of directors includes three executive directors, namely Dr. Chen Yuhong (Chairman and Chief Executive Officer), Dr. He Ning (Vice Chairman) and Dr. Tang Zhenming, and three non-executive directors, namely Dr. Zhang Yaqin and Mr. Gao Liangyu And Ms. Gavriella Schuster, and three independent non-executive directors, namely Mr. Zeng Zhijie, Dr. Lai Guanrong and Professor Wu Lilan.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM